← FDA Drug Approvals (Drugs@FDA)

QUIXIN

NDA · New Drug Application · Sponsor: SANTEN · Approved 2000-08-18

Drug application

FDA Application #

NDA021199

Application type

New Drug Application

Brand name

QUIXIN

Generic name

Levofloxacin

Active ingredients

LEVOFLOXACIN

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

SANTEN

First approval

2000-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown